Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study.

Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM.

Lancet. 2011 Jun 18;377(9783):2085-92. doi: 10.1016/S0140-6736(11)60551-5.

PMID:
21684381
2.

What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination.

Lynge E, Antilla A, Arbyn M, Segnan N, Ronco G.

Eur J Cancer. 2009 Oct;45(15):2714-21. doi: 10.1016/j.ejca.2009.07.024. Epub 2009 Aug 18. Review.

PMID:
19695870
3.

Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.

Rambout L, Hopkins L, Hutton B, Fergusson D.

CMAJ. 2007 Aug 28;177(5):469-79. Epub 2007 Aug 1. Review.

4.

Prophylactic HPV vaccination: a major breakthrough in the fight against cervical cancer?

Saleem A, Tristram A, Fiander A, Hibbitts S.

Minerva Med. 2009 Dec;100(6):503-23. Review.

PMID:
20010484
5.

[Should the antipapillomavirus vaccination after the age of 25 be advised?].

Simon P, Poppe W.

J Gynecol Obstet Biol Reprod (Paris). 2008 Dec;37(8):748-52. doi: 10.1016/j.jgyn.2008.07.003. Epub 2008 Aug 26. Review. French.

6.

Cervical cancer in the human papillomavirus vaccination era.

Tay SK.

Curr Opin Obstet Gynecol. 2012 Feb;24(1):3-7. doi: 10.1097/GCO.0b013e32834daed9. Review.

PMID:
22123221
7.

[Diseases caused by human papilloma viruses].

Zollner U, Schwarz TF.

Dtsch Med Wochenschr. 2011 May;136(20):1067-72. doi: 10.1055/s-0031-1275845. Epub 2011 May 10. Review. German.

PMID:
21560109
8.

Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.

Adams M, Jasani B, Fiander A.

Vaccine. 2007 Apr 20;25(16):3007-13. Epub 2007 Jan 18. Review.

PMID:
17292517
9.

HPV testing and vaccination in Europe.

Leeson SC, Alibegashvili T, Arbyn M, Bergeron C, Carriero C, Mergui JL, Nieminen P, Prendiville W, Redman CW, Rieck GC, Quaas J, Petry KU.

J Low Genit Tract Dis. 2014 Jan;18(1):61-9. doi: 10.1097/LGT.0b013e318286b8d3. Review.

PMID:
23774078
10.

Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.

Poljak M, Seme K, Maver PJ, Kocjan BJ, Cuschieri KS, Rogovskaya SI, Arbyn M, Syrjänen S.

Vaccine. 2013 Dec 31;31 Suppl 7:H59-70. doi: 10.1016/j.vaccine.2013.03.029. Review.

PMID:
24332298
11.

The future of cervical cancer prevention: human papillomavirus vaccines.

Cadman L.

J Fam Health Care. 2008;18(4):131-2. Review.

PMID:
18754553
12.

Cervical cancer prevention in Australia: Planning for the future.

Saville AM.

Cancer Cytopathol. 2016 Apr;124(4):235-40. doi: 10.1002/cncy.21643. Epub 2015 Nov 30. Review.

13.

Assessing mandatory HPV vaccination: who should call the shots?

Javitt G, Berkowitz D, Gostin LO.

J Law Med Ethics. 2008 Summer;36(2):384-95, 214. doi: 10.1111/j.1748-720X.2008.00282.x. Review.

PMID:
18547207
14.

Cervical cancer screening in Australia: Past and present.

Farnsworth A.

Cancer Cytopathol. 2016 Apr;124(4):231-4. doi: 10.1002/cncy.21642. Epub 2015 Oct 29. Review. No abstract available.

Supplemental Content

Support Center